{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:40:14Z","timestamp":1795149614469,"version":"4.10.3"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s43440-022-00377-w","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:06:50Z","timestamp":1656590810000},"page":"847-858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-4702","authenticated-orcid":false,"given":"Nadia","family":"Sawicka-Gutaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-2379","authenticated-orcid":false,"given":"Natalia","family":"Zawalna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-175X","authenticated-orcid":false,"given":"Pawe\u0142","family":"Gut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9743-2405","authenticated-orcid":false,"given":"Marek","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"issue":"11","key":"377_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13260","volume":"19","author":"BR Gauthier","year":"2020","unstructured":"Gauthier BR, Sola-Garc\u00eda A, C\u00e1liz-Molina M\u00c1, Lorenzo PI, Cobo-Vuilleumier N, Capilla-Gonz\u00e1lez V, et al. Thyroid hormones in diabetes, cancer, and aging. Aging Cell. 2020;19(11): e13260.","journal-title":"Aging Cell"},{"issue":"9","key":"377_CR2","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI60047","volume":"122","author":"GA Brent","year":"2012","unstructured":"Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122(9):3035\u201343.","journal-title":"J Clin Invest"},{"issue":"7","key":"377_CR3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1210\/en.2017-00250","volume":"158","author":"F Flamant","year":"2017","unstructured":"Flamant F, Cheng SY, Hollenberg AN, Moeller LC, Samarut J, Wondisford FE, et al. Thyroid hormone signaling pathways: time for a more precise nomenclature. Endocrinology. 2017;158(7):2052\u20137.","journal-title":"Endocrinology"},{"issue":"2","key":"377_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/physrev.00030.2013","volume":"94","author":"R Mullur","year":"2014","unstructured":"Mullur R, Liu Y-Y, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355\u201382.","journal-title":"Physiol Rev"},{"key":"377_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fendo.2018.00511","volume":"9","author":"LH Duntas","year":"2018","unstructured":"Duntas LH, Brenta G. A renewed focus on the association between thyroid hormones and lipid metabolism. Front Endocrinol (Lausanne). 2018;9:511.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"377_CR6","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/JME-17-0319","volume":"60","author":"KA Iwen","year":"2018","unstructured":"Iwen KA, Oelkrug R, Brabant G. Effects of thyroid hormones on thermogenesis and energy partitioning. J Mol Endocrinol. 2018;60(3):R157\u201370.","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"377_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1210\/er.2013-1006","volume":"35","author":"E Yehuda-Shnaidman","year":"2014","unstructured":"Yehuda-Shnaidman E, Kalderon B, Bar-Tana J. Thyroid hormone, thyromimetics, and metabolic efficiency. Endocr Rev. 2014;35(1):35\u201358.","journal-title":"Endocr Rev"},{"issue":"2","key":"377_CR8","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1530\/EC-20-0562","volume":"10","author":"SC Sentis","year":"2021","unstructured":"Sentis SC, Oelkrug R, Mittag J. Thyroid hormones in the regulation of brown adipose tissue thermogenesis. Endocr Connect. 2021;10(2):R106\u201315.","journal-title":"Endocr Connect"},{"issue":"4","key":"377_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/metabo12040336","volume":"12","author":"N Sawicka-Gutaj","year":"2022","unstructured":"Sawicka-Gutaj N, Erampamoorthy A, Zybek-Kocik A, Kyriacou A, Zgorzalewicz-Stachowiak M, Czarnywojtek A, et al. The role of thyroid hormones on skeletal muscle thermogenesis. Metabolites. 2022;12(4):336.","journal-title":"Metabolites"},{"issue":"1","key":"377_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2013.06.006","volume":"379","author":"F Cioffi","year":"2013","unstructured":"Cioffi F, Senese R, Lanni A, Goglia F. Thyroid hormones and mitochondria: With a brief look at derivatives and analogues. Mol Cell Endocrinol. 2013;379(1):51\u201361.","journal-title":"Mol Cell Endocrinol"},{"issue":"536","key":"377_CR11","doi-asserted-by":"publisher","first-page":"eaam5855","DOI":"10.1126\/scisignal.aam5855","volume":"11","author":"BK Singh","year":"2018","unstructured":"Singh BK, Sinha RA, Tripathi M, Mendoza A, Ohba K, Sy JAC, et al. Thyroid hormone receptor and ERR\u03b1 coordinately regulate mitochondrial fission, mitophagy, biogenesis, and function. Sci Signal. 2018;11(536):eaam5855.","journal-title":"Sci Signal"},{"issue":"5","key":"377_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/jnc.13093","volume":"133","author":"R Kapoor","year":"2015","unstructured":"Kapoor R, Fanibunda SE, Desouza LA, Guha SK, Vaidya VA. Perspectives on thyroid hormone action in adult neurogenesis. J Neurochem. 2015;133(5):599\u2013616.","journal-title":"J Neurochem"},{"issue":"6","key":"377_CR13","first-page":"238","volume":"11","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, Haorah J. How does the brain remove its waste metabolites from within? Int J Physiol Pathophysiol Pharmacol. 2019;11(6):238\u201349.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"377_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13044-015-0013-7","volume":"8","author":"RG Ahmed","year":"2015","unstructured":"Ahmed RG. Hypothyroidism and brain developmental players. Thyroid Res. 2015;8:2.","journal-title":"Thyroid Res"},{"key":"377_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mce.2017.01.041","volume":"458","author":"K Landers","year":"2017","unstructured":"Landers K, Richard K. Traversing barriers: how thyroid hormones pass placental, blood-brain and blood-cerebrospinal fluid barriers. Mol Cell Endocrinol. 2017;458:22\u20138.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"377_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4183\/aeb.2016.1","volume":"12","author":"JH Lazarus","year":"2016","unstructured":"Lazarus JH, Taylor PN. Hypothyroxinaemia and brain development. Acta Endocrinol (Buchar). 2016;12(1):1\u20136.","journal-title":"Acta Endocrinol (Buchar)"},{"key":"377_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fendo.2019.00209","volume":"10","author":"BK Stepien","year":"2019","unstructured":"Stepien BK, Huttner WB. Transport, metabolism, and function of thyroid hormones in the developing mammalian brain. Front Endocrinol (Lausanne). 2019;10:209.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"377_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ncpendmet1026","volume":"5","author":"SY Chan","year":"2009","unstructured":"Chan SY, Vasilopoulou E, Kilby MD. The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metab. 2009;5(1):45\u201354.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"6","key":"377_CR19","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00429-019-01896-8","volume":"224","author":"D L\u00f3pez-Esp\u00edndola","year":"2019","unstructured":"L\u00f3pez-Esp\u00edndola D, Garc\u00eda-Aldea \u00c1, G\u00f3mez de la Riva I, Rodr\u00edguez-Garc\u00eda AM, Salvatore D, Visser TJ, et al. Thyroid hormone availability in the human fetal brain: novel entry pathways and role of radial glia. Brain Struct Funct. 2019;224(6):2103\u201319.","journal-title":"Brain Struct Funct"},{"issue":"1","key":"377_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ymgme.2021.12.003","volume":"135","author":"S Masnada","year":"2022","unstructured":"Masnada S, Sarret C, Antonello CE, Fadilah A, Krude H, Mura E, et al. Movement disorders in MCT8 deficiency\/Allan-Herndon-Dudley Syndrome. Mol Genet Metab. 2022;135(1):109\u201313.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"377_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074621","volume":"8","author":"TB Rodrigues","year":"2013","unstructured":"Rodrigues TB, Ceballos A, Grijota-Mart\u00ednez C, Nu\u00f1ez B, Refetoff S, Cerd\u00e1n S, et al. Increased oxidative metabolism and neurotransmitter cycling in the brain of mice lacking the thyroid hormone transporter Slc16a2 (Mct8). PLoS ONE. 2013;8(10): e74621.","journal-title":"PLoS ONE"},{"issue":"11","key":"377_CR22","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1089\/thy.2018.0595","volume":"28","author":"P Str\u00f8mme","year":"2018","unstructured":"Str\u00f8mme P, Groeneweg S, Lima de Souza EC, Zevenbergen C, Torgersbr\u00e5ten A, Holmgren A, et al. Mutated thyroid hormone transporter OATP1C1 associates with severe brain hypometabolism and Juvenile neurodegeneration. Thyroid. 2018;28(11):1406\u201315.","journal-title":"Thyroid"},{"issue":"2","key":"377_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/10408363.2016.1269309","volume":"54","author":"D Springer","year":"2017","unstructured":"Springer D, Jiskra J, Limanova Z, Zima T, Potlukova E. Thyroid in pregnancy: from physiology to screening. Crit Rev Clin Lab Sci. 2017;54(2):102\u201316.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1\u20132","key":"377_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/00365513.2018.1555858","volume":"79","author":"SL Andersen","year":"2019","unstructured":"Andersen SL. Frequency and outcomes of maternal thyroid function abnormalities in early pregnancy. Scand J Clin Lab Invest. 2019;79(1\u20132):99\u2013107.","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"377_CR25","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1542\/neo.21-1-e37","volume":"21","author":"A Weiner","year":"2020","unstructured":"Weiner A, Oberfield S, Vuguin P. The laboratory features of congenital hypothyroidism and approach to therapy. NeoReviews. 2020;21(1):e37-44.","journal-title":"NeoReviews"},{"key":"377_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.772382","volume":"15","author":"K Uchida","year":"2021","unstructured":"Uchida K, Suzuki M. Congenital hypothyroidism and brain development: association with other psychiatric disorders. Front Neurosci. 2021;15: 772382.","journal-title":"Front Neurosci"},{"key":"377_CR27","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3389\/fneur.2019.01103","volume":"10","author":"D Talhada","year":"2019","unstructured":"Talhada D, Santos CRA, Gon\u00e7alves I, Ruscher K. Thyroid hormones in the brain and their impact in recovery mechanisms after stroke. Front Neurol. 2019;10:1103.","journal-title":"Front Neurol"},{"issue":"17","key":"377_CR28","doi-asserted-by":"publisher","first-page":"9913","DOI":"10.1073\/pnas.171319498","volume":"98","author":"Y Itoh","year":"2001","unstructured":"Itoh Y, Esaki T, Kaneshige M, Suzuki H, Cook M, Sokoloff L, et al. Brain glucose utilization in mice with a targeted mutation in the thyroid hormone \u03b1 or \u03b2 receptor gene. Proc Natl Acad Sci USA. 2001;98(17):9913\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"377_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcdb.2020.07.017","volume":"112","author":"JA Lee","year":"2021","unstructured":"Lee JA, Hall B, Allsop J, Alqarni R, Allen SP. Lipid metabolism in astrocytic structure and function. Semin Cell Dev Biol. 2021;112:123\u201336.","journal-title":"Semin Cell Dev Biol"},{"issue":"11","key":"377_CR30","doi-asserted-by":"publisher","first-page":"25959","DOI":"10.3390\/ijms161125939","volume":"16","author":"A Falkowska","year":"2015","unstructured":"Falkowska A, Gutowska I, Goschorska M, Nowacki P, Chlubek D, Baranowska-Bosiacka I. Energy metabolism of the brain, including the cooperation between astrocytes and neurons, especially in the context of glycogen metabolism. Int J Mol Sci. 2015;16(11):25959\u201381.","journal-title":"Int J Mol Sci"},{"key":"377_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/472459","volume":"2014","author":"A Panov","year":"2014","unstructured":"Panov A, Orynbayeva Z, Vavilin V, Lyakhovich V. Fatty acids in energy metabolism of the central nervous system. Biomed Res Int. 2014;2014: 472459.","journal-title":"Biomed Res Int"},{"issue":"13","key":"377_CR32","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1523\/JNEUROSCI.23-13-05928.2003","volume":"23","author":"D Ebert","year":"2003","unstructured":"Ebert D, Haller RG, Walton ME. Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J Neurosci. 2003;23(13):5928\u201335.","journal-title":"J Neurosci"},{"issue":"11","key":"377_CR33","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/cells8111424","volume":"8","author":"S Kuhn","year":"2019","unstructured":"Kuhn S, Gritti L, Crooks D, Dombrowski Y. Oligodendrocytes in development, myelin generation and beyond. Cells. 2019;8(11):1424.","journal-title":"Cells"},{"issue":"2","key":"377_CR34","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/jcm9020470","volume":"9","author":"D Marangon","year":"2020","unstructured":"Marangon D, Boccazzi M, Lecca D, Fumagalli M. Regulation of oligodendrocyte functions: targeting lipid metabolism and extracellular matrix for myelin repair. J Clin Med. 2020;9(2):470.","journal-title":"J Clin Med"},{"key":"377_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fncel.2017.00024","volume":"11","author":"S J\u00e4kel","year":"2017","unstructured":"J\u00e4kel S, Dimou L. Glial cells and their function in the adult brain: a journey through the history of their ablation. Front Cell Neurosci. 2017;11:24.","journal-title":"Front Cell Neurosci"},{"key":"377_CR36","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/bs.vh.2017.05.004","volume":"106","author":"M Das","year":"2018","unstructured":"Das M, Ghosh M, Gharami K, Das S. Thyroid hormone and astrocyte differentiation. Vitam Horm. 2018;106:283\u2013312.","journal-title":"Vitam Horm"},{"key":"377_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fendo.2014.00082","volume":"5","author":"B Morte","year":"2014","unstructured":"Morte B, Bernal J. Thyroid hormone action: astrocyte-neuron communication. Front Endocrinol (Lausanne). 2014;5:82. https:\/\/doi.org\/10.3389\/fendo.2014.00082.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"377_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fncel.2015.00194","volume":"9","author":"M Noda","year":"2015","unstructured":"Noda M. Possible role of glial cells in the relationship between thyroid dysfunction and mental disorders. Front Cell Neurosci. 2015;9:194.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"377_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/jne.12283","volume":"27","author":"RS Dezonne","year":"2015","unstructured":"Dezonne RS, Lima FRS, Trentin AG, Gomes FC. Thyroid hormone and astroglia: endocrine control of the neural environment. J Neuroendocrinol. 2015;27(6):435\u201345.","journal-title":"J Neuroendocrinol"},{"issue":"6\u20137","key":"377_CR40","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.bbabio.2010.01.004","volume":"1797","author":"I Bratic","year":"2010","unstructured":"Bratic I, Trifunovic A. Mitochondrial energy metabolism and ageing. Biochim Biophys Acta. 2010;1797(6\u20137):961\u20137.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"377_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1210\/er.2012-1056","volume":"34","author":"J Bowers","year":"2013","unstructured":"Bowers J, Terrien J, Clerget-Froidevaux MS, Gothi\u00e9 JD, Rozing MP, Westendorp RGJ, et al. Thyroid hormone signaling and homeostasis during aging. Endocr Rev. 2013;34(4):556\u201389.","journal-title":"Endocr Rev"},{"issue":"11","key":"377_CR42","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1210\/jc.2010-0875","volume":"95","author":"MP Rozing","year":"2010","unstructured":"Rozing MP, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Fr\u00f6lich M, de Craen AJM, et al. Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab. 2010;95(11):4979\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"377_CR43","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1210\/jc.2009-0808","volume":"94","author":"G Atzmon","year":"2009","unstructured":"Atzmon G, Barzilai N, Surks MI, Gabriely I. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab. 2009;94(12):4768\u201375.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"377_CR44","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489\u201399.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"377_CR45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1530\/eje.0.1330646","volume":"133","author":"A Giustina","year":"1995","unstructured":"Giustina A, Wehrenberg WB. Influence of thyroid hormones on the regulation of growth hormone secretion. Eur J Endocrinol. 1995;133(6):646\u201353.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"377_CR46","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11357-011-9264-y","volume":"34","author":"F Derbr\u00e9","year":"2012","unstructured":"Derbr\u00e9 F, Gomez-Cabrera MC, Nascimento AL, Sanchis-Gomar F, Martinez-Bello VE, Tresguerres JAF, et al. Age associated low mitochondrial biogenesis may be explained by lack of response of PGC-1\u03b1 to exercise training. Age (Dordr). 2012;34(3):669\u201379.","journal-title":"Age (Dordr)"},{"issue":"2","key":"377_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/path.3984","volume":"227","author":"L Varela","year":"2012","unstructured":"Varela L, Mart\u00ednez-S\u00e1nchez N, Gallego R, V\u00e1zquez MJ, Roa J, G\u00e1ndara M, et al. Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism. J Pathol. 2012;227(2):209\u201322.","journal-title":"J Pathol"},{"key":"377_CR48","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.17196.1","volume":"8","author":"D Papadopoli","year":"2019","unstructured":"Papadopoli D, Boulay K, Kazak L, Pollak M, Mallette FA, Topisirovic I, et al. mTOR as a central regulator of lifespan and aging. F1000Res. 2019;8:F1000.","journal-title":"F1000Res"},{"issue":"Suppl 2","key":"377_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12325-019-01080-8","volume":"36","author":"L Chiovato","year":"2019","unstructured":"Chiovato L, Magri F, Carl\u00e9 A. Hypothyroidism in context: where we\u2019ve been and where we\u2019re going. Adv Ther. 2019;36(Suppl 2):47\u201358.","journal-title":"Adv Ther"},{"issue":"10101","key":"377_CR50","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550\u201362.","journal-title":"Lancet"},{"issue":"2","key":"377_CR51","doi-asserted-by":"publisher","first-page":"bvab194","DOI":"10.1210\/jendso\/bvab194","volume":"6","author":"M Jurado-Flores","year":"2022","unstructured":"Jurado-Flores M, Warda F, Mooradian A. Pathophysiology and clinical features of neuropsychiatric manifestations of thyroid disease. J Endocr Soc. 2022;6(2):bvab194.","journal-title":"J Endocr Soc"},{"issue":"2","key":"377_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.12740\/PP\/112470","volume":"55","author":"M Przybylak","year":"2021","unstructured":"Przybylak M, Grabowski J, Bidzan L. Cognitive functions and thyroid hormones secretion disorders. Psychiatr Pol. 2021;55(2):309\u201321.","journal-title":"Psychiatr Pol"},{"issue":"8","key":"377_CR53","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1210\/jc.2008-2235","volume":"94","author":"M Bauer","year":"2009","unstructured":"Bauer M, Silverman DHS, Schlagenhauf F, London ED, Geist CL, van Herle K, et al. Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab. 2009;94(8):2922\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"377_CR54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11011-018-0318-z","volume":"34","author":"J Bladowska","year":"2019","unstructured":"Bladowska J, Waliszewska-Pros\u00f3\u0142 M, Ejma M, S\u0105siadek M. The metabolic alterations within the normal appearing brain in patients with Hashimoto\u2019s thyroiditis are correlated with hormonal changes. Metab Brain Dis. 2019;34(1):53\u201360.","journal-title":"Metab Brain Dis"},{"key":"377_CR55","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1038\/s41598-021-82281-6","volume":"11","author":"M Waliszewska-Pros\u00f3\u0142","year":"2021","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Bladowska J, Budrewicz S, S\u0105siadek M, Dziadkowiak E, Ejma M. The evaluation of Hashimoto\u2019s thyroiditis with event-related potentials and magnetic resonance spectroscopy and its relation to cognitive function. Sci Rep. 2021;11:2480.","journal-title":"Sci Rep"},{"key":"377_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2022.105710","volume":"139","author":"P Quinlan","year":"2022","unstructured":"Quinlan P, Horvath A, Eckerstr\u00f6m C, Wallin A, Svensson J. Higher thyroid function is associated with accelerated hippocampal volume loss in Alzheimer\u2019s disease. Psychoneuroendocrinology. 2022;139: 105710.","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"377_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12707","volume":"31","author":"A G\u00f6bel","year":"2019","unstructured":"G\u00f6bel A, Heldmann M, G\u00f6ttlich M, Goerges R, Nieberding R, Sartorius A, et al. Partial withdrawal of levothyroxine treated disease leads to brain activations and effects on performance in a working memory task: a pilot study. J Neuroendocrinol. 2019;31(4): e12707.","journal-title":"J Neuroendocrinol"},{"issue":"06\/07","key":"377_CR58","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1055\/a-1101-9090","volume":"128","author":"A G\u00f6bel","year":"2020","unstructured":"G\u00f6bel A, G\u00f6ttlich M, Reinwald J, Rogge B, Uter JC, Heldmann M, et al. The Influence of thyroid hormones on brain structure and function in humans. Exp Clin Endocrinol Diabetes. 2020;128(06\/07):432\u20136.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"377_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.779693","volume":"23","author":"S Zhao","year":"2021","unstructured":"Zhao S, Xia Y, Huang Y, Zou H, Wang X, Chen Z, et al. The correlation between thyroid function, frontal gray matter, and executive function in patients with major depressive disorder. Front Endocrinol (Lausanne). 2021;23(12): 779693.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"26","key":"377_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102250","volume":"19","author":"J Uter","year":"2020","unstructured":"Uter J, Heldmann M, Rogge B, Obst M, Steinhardt J, Brabant G, et al. Patients with mutations of the Thyroid hormone beta-receptor show an ADHD-like phenotype for performance monitoring: an electrophysiological study. Neuroimage Clin. 2020;19(26): 102250.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"377_CR61","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0473","volume":"11","author":"M Heldmann","year":"2022","unstructured":"Heldmann M, Chatterjee K, Moran C, Rogge B, Steinhardt J, Wagner-Altendorf T, et al. Reduced pituitary size in subjects with mutations in the THRB gene and thyroid hormone resistance. Endocr Connect. 2022;11(1): e210473.","journal-title":"Endocr Connect"},{"issue":"5","key":"377_CR62","doi-asserted-by":"publisher","first-page":"505","DOI":"10.5603\/EP.a2021.0091","volume":"72","author":"D Dadej","year":"2021","unstructured":"Dadej D, Skraba K, Matyjaszek-Matuszek B, \u015awirska J, Rucha\u0142a M, Ziemnicka K. Presenting symptoms and endocrine dysfunction in Rathke cleft cysts - a two-centre experience. Endokrynol Pol. 2021;72(5):505\u201311.","journal-title":"Endokrynol Pol"},{"issue":"2","key":"377_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","volume":"322","author":"B Biondi","year":"2019","unstructured":"Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019;322(2):153\u201360.","journal-title":"JAMA"},{"issue":"2","key":"377_CR64","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3949\/ccjm.86a.17053","volume":"86","author":"S Azim","year":"2019","unstructured":"Azim S, Nasr C. Subclinical hypothyroidism: when to treat. Cleve Clin J Med. 2019;86(2):101\u201310.","journal-title":"Cleve Clin J Med"},{"key":"377_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.582519","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yang Y, Tao B, Lv Q, Lui S, He L. Gray matter and regional brain activity abnormalities in subclinical hypothyroidism. Front Endocrinol (Lausanne). 2021;12: 582519.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"377_CR66","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1210\/jc.2016-2129","volume":"101","author":"C Rieben","year":"2016","unstructured":"Rieben C, Segna D, da Costa BR, Collet T-H, Chaker L, Aubert CE, et al. Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies. J Clin Endocrinol Metab. 2016;101(12):4945\u201354.","journal-title":"J Clin Endocrinol Metab"},{"key":"377_CR67","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fnagi.2015.00150","volume":"7","author":"AA Akintola","year":"2015","unstructured":"Akintola AA, Jansen SW, van Bodegom D, van der Grond J, Westendorp RG, de Craen AJM, et al. Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis. Front Aging Neurosci. 2015;7:150.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"377_CR68","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10072-011-0813-z","volume":"33","author":"I Mazz\u00f9","year":"2012","unstructured":"Mazz\u00f9 I, Mosti S, Caltagirone C, Carlesimo GA. Hashimoto\u2019s encephalopathy: neuropsychological findings. Neurol Sci. 2012;33(3):653\u20136.","journal-title":"Neurol Sci"},{"issue":"3","key":"377_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/ane.12618","volume":"135","author":"JY Zhou","year":"2017","unstructured":"Zhou JY, Xu B, Lopes J, Blamoun J, Li L. Hashimoto encephalopathy: literature review. Acta Neurol Scand. 2017;135(3):285\u201390.","journal-title":"Acta Neurol Scand"},{"issue":"12","key":"377_CR70","first-page":"e11857","volume":"12","author":"A Sliwinska","year":"2020","unstructured":"Sliwinska A, Fumuso P, Stringer B, Ansar M, Baldwin J. Hashimoto encephalopathy with status epilepticus. Cureus. 2020;12(12):e11857.","journal-title":"Cureus"},{"issue":"6","key":"377_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.101364","volume":"33","author":"LP Churilov","year":"2019","unstructured":"Churilov LP, Sobolevskaia PA, Stroev YI. Thyroid gland and brain: enigma of Hashimoto\u2019s encephalopathy. Best Pract Res Clin Endocrinol Metab. 2019;33(6): 101364.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"377_CR72","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2165\/00023210-200721100-00002","volume":"21","author":"R Mocellin","year":"2007","unstructured":"Mocellin R, Walterfang M, Velakoulis D. Hashimoto\u2019s encephalopathy. CNS Drugs. 2007;21(10):799\u2013811.","journal-title":"CNS Drugs"},{"issue":"1","key":"377_CR73","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jns.2010.11.027","volume":"302","author":"K Moodley","year":"2011","unstructured":"Moodley K, Botha J, Raidoo DM, Naidoo S. Immuno-localisation of anti-thyroid antibodies in adult human cerebral cortex. J Neurol Sci. 2011;302(1):114\u20137.","journal-title":"J Neurol Sci"},{"issue":"6","key":"377_CR74","first-page":"e15697","volume":"13","author":"V Jegatheeswaran","year":"2020","unstructured":"Jegatheeswaran V, Chan M, Chen YA. MRI findings of two patients with hashimoto encephalopathy. Cureus. 2020;13(6):e15697.","journal-title":"Cureus"},{"issue":"1","key":"377_CR75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jns.2004.08.015","volume":"228","author":"DJ Mahad","year":"2005","unstructured":"Mahad DJ, Staugaitis S, Ruggieri P, Parisi J, Kleinschmidt-Demasters BK, Lassmann H, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci. 2005;228(1):3\u20135.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"377_CR76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jns.2010.09.019","volume":"300","author":"N Chen","year":"2011","unstructured":"Chen N, Qin W, Wei C, Wang X, Li K. Time course of Hashimoto\u2019s encephalopathy revealed by MRI: report of two cases. J Neurol Sci. 2011;300(1\u20132):169\u201372.","journal-title":"J Neurol Sci"},{"issue":"10047","key":"377_CR77","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","volume":"388","author":"S De Leo","year":"2016","unstructured":"De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906\u201318.","journal-title":"Lancet"},{"issue":"5","key":"377_CR78","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"PN Taylor","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301\u201316.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"377_CR79","doi-asserted-by":"publisher","first-page":"124","DOI":"10.21037\/gs.2019.11.01","volume":"9","author":"AR Doubleday","year":"2020","unstructured":"Doubleday AR, Sippel RS. Hyperthyroidism. Gland Surg. 2020;9(1):124\u201335.","journal-title":"Gland Surg"},{"issue":"6","key":"377_CR80","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3413\/nukmed-0191","volume":"47","author":"M Schmidt","year":"2008","unstructured":"Schmidt M, Huff W, Dietlein M, Kobe C, Schicha H. Interactions between brain, psyche and thyroid. Nuklearmedizin. 2008;47(6):225\u201334.","journal-title":"Nuklearmedizin"},{"key":"377_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.739917","volume":"15","author":"M Kumar","year":"2021","unstructured":"Kumar M, Singh S, Rana P, Kumar P, Sekhri T, Kanwar R, et al. Neurometabolite changes in hyperthyroid patients before and after antithyroid treatment: an in vivo 1H MRS study. Front Hum Neurosci. 2021;15: 739917.","journal-title":"Front Hum Neurosci"},{"issue":"12","key":"377_CR82","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1210\/jc.2006-0573","volume":"91","author":"MF Schreckenberger","year":"2006","unstructured":"Schreckenberger MF, Egle UT, Drecker S, Buchholz HG, Weber MM, Bartenstein P, et al. Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J Clin Endocrinol Metab. 2006;91(12):4786\u201391.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"377_CR83","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1210\/clinem\/dgab808","volume":"107","author":"M Holmberg","year":"2022","unstructured":"Holmberg M, Malmgren H, Heckemann RA, et al. A longitudinal study of medial temporal lobe volumes in graves disease. J Clin Endocrinol Metab. 2022;107(4):1040\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"377_CR84","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.ejrad.2013.09.019","volume":"83","author":"W Zhang","year":"2014","unstructured":"Zhang W, Song L, Yin X, Zhang J, Liu C, Wang J, et al. Grey matter abnormalities in untreated hyperthyroidism: a voxel-based morphometry study using the DARTEL approach. Eur J Radiol. 2014;83(1):e43-48.","journal-title":"Eur J Radiol"},{"issue":"6","key":"377_CR85","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.3390\/ijms21061989","volume":"21","author":"A Rabbito","year":"2020","unstructured":"Rabbito A, Dulewicz M, Kulczy\u0144ska-Przybik A, Mroczko B. Biochemical markers in Alzheimer\u2019s disease. Int J Mol Sci. 2020;21(6):1989.","journal-title":"Int J Mol Sci"},{"issue":"10284","key":"377_CR86","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390.","journal-title":"Lancet"},{"issue":"1","key":"377_CR87","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/neup.12626","volume":"40","author":"R Sengoku","year":"2020","unstructured":"Sengoku R. Aging and Alzheimer\u2019s disease pathology. Neuropathology. 2020;40(1):22\u20139.","journal-title":"Neuropathology"},{"key":"377_CR88","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.REV120.008207","volume":"296","author":"P Lei","year":"2020","unstructured":"Lei P, Ayton S, Bush AI. The essential elements of Alzheimer\u2019s disease. J Biol Chem. 2020;296: 100105.","journal-title":"J Biol Chem"},{"issue":"7","key":"377_CR89","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s11011-021-00760-1","volume":"36","author":"PBS Figueroa","year":"2021","unstructured":"Figueroa PBS, Ferreira AFF, Britto LR, Doussoulin AP, da Torr\u00e3o AS. Association between thyroid function and Alzheimer\u2019s disease: a systematic review. Metab Brain Dis. 2021;36(7):1523\u201343.","journal-title":"Metab Brain Dis"},{"issue":"7","key":"377_CR90","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.psyneuen.2012.10.012","volume":"38","author":"P Johansson","year":"2013","unstructured":"Johansson P, Almqvist EG, Johansson J-O, Mattsson N, Hansson O, Wallin A, et al. Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer\u2019s disease. Psychoneuroendocrinology. 2013;38(7):1058\u201366.","journal-title":"Psychoneuroendocrinology"},{"key":"377_CR91","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13195-017-0291-5","volume":"9","author":"HJ Choi","year":"2017","unstructured":"Choi HJ, Byun MS, Yi D, Sohn BK, Lee JH, Lee J-Y, et al. Associations of thyroid hormone serum levels with in-vivo Alzheimer\u2019s disease pathologies. Alzheimers Res Ther. 2017;9:64.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"377_CR92","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.neuint.2012.01.027","volume":"60","author":"C Contreras-Jurado","year":"2012","unstructured":"Contreras-Jurado C, Pascual A. Thyroid hormone regulation of APP (\u03b2-amyloid precursor protein) gene expression in brain and brain cultured cells. Neurochemistry Int. 2012;60(5):484\u20137.","journal-title":"Neurochemistry Int"},{"issue":"1\u20132","key":"377_CR93","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mce.2011.03.016","volume":"339","author":"M Belakavadi","year":"2011","unstructured":"Belakavadi M, Dell J, Grover GJ, Fondell JD. Thyroid hormone suppression of \u03b2-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events. Mol Cell Endocrinol. 2011;339(1\u20132):72\u201380.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"377_CR94","first-page":"104","volume":"1","author":"CE Oldham","year":"2018","unstructured":"Oldham CE, Wooten CJ, Williams AB, Dixon S, Lopez D. Thyroid hormone enhances neurite outgrowth in neuroscreen 1 cells. Int J Biomed Investig. 2018;1(1):104.","journal-title":"Int J Biomed Investig"},{"issue":"4","key":"377_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214676","volume":"14","author":"S Nomoto","year":"2019","unstructured":"Nomoto S, Kinno R, Ochiai H, Kubota S, Mori Y, Futamura A, et al. The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer\u2019s disease. PLoS ONE. 2019;14(4): e0214676.","journal-title":"PLoS ONE"},{"key":"377_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2020.104844","volume":"121","author":"P Quinlan","year":"2020","unstructured":"Quinlan P, Horvath A, Eckerstr\u00f6m C, Wallin A, Svensson J. Altered thyroid hormone profile in patients with Alzheimer\u2019s disease. Psychoneuroendocrinology. 2020;121: 104844.","journal-title":"Psychoneuroendocrinology"},{"issue":"18","key":"377_CR97","first-page":"3211","volume":"125","author":"N Zhang","year":"2012","unstructured":"Zhang N, Du H, Wang J, Cheng Y. A pilot study on the relationship between thyroid status and neuropsychiatric symptoms in patients with Alzheimer disease. Chin Med J (Engl). 2012;125(18):3211\u20136.","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"377_CR98","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s10072-019-03863-x","volume":"40","author":"TO Tobore","year":"2019","unstructured":"Tobore TO. On the central role of mitochondria dysfunction and oxidative stress in Alzheimer\u2019s disease. Neurol Sci. 2019;40(8):1527\u201340.","journal-title":"Neurol Sci"},{"issue":"9","key":"377_CR99","doi-asserted-by":"publisher","first-page":"14633","DOI":"10.1002\/jcp.28198","volume":"234","author":"K Bavarsad","year":"2019","unstructured":"Bavarsad K, Hosseini M, Hadjzadeh MAR, Sahebkar A. The effects of thyroid hormones on memory impairment and Alzheimer\u2019s disease. J Cell Physiol. 2019;234(9):14633\u201340.","journal-title":"J Cell Physiol"},{"issue":"6","key":"377_CR100","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/glia.23247","volume":"66","author":"D Boison","year":"2018","unstructured":"Boison D, Steinh\u00e4user C. Epilepsy and astrocyte energy metabolism. Glia. 2018;66(6):1235\u201343.","journal-title":"Glia"},{"issue":"5","key":"377_CR101","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41583-019-0126-4","volume":"20","author":"DC Patel","year":"2019","unstructured":"Patel DC, Tewari BP, Chaunsali L, Sontheimer H. Neuron\u2013glia interactions in the pathophysiology of epilepsy. Nat Rev Neurosci. 2019;20(5):282\u201397.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"377_CR102","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000503831","volume":"54","author":"E Beghi","year":"2020","unstructured":"Beghi E. The Epidemiology of Epilepsy. Neuroepidemiology. 2020;54(2):185\u201391.","journal-title":"Neuroepidemiology"},{"key":"377_CR103","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.seizure.2020.09.015","volume":"82","author":"I Mukhtar","year":"2020","unstructured":"Mukhtar I. Inflammatory and immune mechanisms underlying epileptogenesis and epilepsy: From pathogenesis to treatment target. Seizure. 2020;82:65\u201379.","journal-title":"Seizure"},{"issue":"4","key":"377_CR104","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/cells7040026","volume":"7","author":"T Hiragi","year":"2018","unstructured":"Hiragi T, Ikegaya Y, Koyama R. Microglia after seizures and in epilepsy. Cells. 2018;7(4):26.","journal-title":"Cells"},{"key":"377_CR105","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.seizure.2015.07.021","volume":"31","author":"SMS Tamijani","year":"2015","unstructured":"Tamijani SMS, Karimi B, Amini E, Golpich M, Dargahi L, Ali RA, et al. Thyroid hormones: possible roles in epilepsy pathology. Seizure. 2015;31:155\u201364.","journal-title":"Seizure"},{"key":"377_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105470","volume":"158","author":"RE Fulton","year":"2021","unstructured":"Fulton RE, Pearson-Smith JN, Huynh CQ, Fabisiak T, Liang L-P, Aivazidis S, et al. Neuron-specific mitochondrial oxidative stress results in epilepsy, glucose dysregulation and a striking astrocyte response. Neurobiol Dis. 2021;158: 105470.","journal-title":"Neurobiol Dis"},{"key":"377_CR107","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.freeradbiomed.2013.02.002","volume":"62","author":"S Rowley","year":"2013","unstructured":"Rowley S, Patel M. Mitochondrial involvement and oxidative stress in temporal lobe epilepsy. Free Radic Biol Med. 2013;62:121\u201331.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"377_CR108","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0301-0082(00)00022-8","volume":"63","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Patterson PH. The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol. 2001;63(2):125\u201349.","journal-title":"Prog Neurobiol"},{"issue":"11","key":"377_CR109","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/NEN.0000000000000002","volume":"72","author":"L Kandratavicius","year":"2013","unstructured":"Kandratavicius L, Monteiro MR, Assirati JA, Carlotti CG, Hallak JE, Leite JP. Neurotrophins in mesial temporal lobe epilepsy with and without psychiatric comorbidities. J Neuropathol Exp Neurol. 2013;72(11):1029\u201342.","journal-title":"J Neuropathol Exp Neurol"},{"key":"377_CR110","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.npep.2018.09.005","volume":"72","author":"L Iughetti","year":"2018","unstructured":"Iughetti L, Lucaccioni L, Fugetto F, Predieri B, Berardi A, Ferrari F. Brain-derived neurotrophic factor and epilepsy: a systematic review. Neuropeptides. 2018;72:23\u20139.","journal-title":"Neuropeptides"},{"issue":"1","key":"377_CR111","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2478\/enr-2021-0002","volume":"55","author":"II Bilous","year":"2021","unstructured":"Bilous II, Pavlovych LL, Kamyshnyi AM. Primary hypothyroidism and autoimmune thyroiditis alter the transcriptional activity of genes regulating neurogenesis in the blood of patients. Endocr Regul. 2021;55(1):5\u201315.","journal-title":"Endocr Regul"},{"issue":"3","key":"377_CR112","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0920-1211(97)00087-9","volume":"29","author":"SY Kim","year":"1998","unstructured":"Kim SY, Smith MA, Post RM, Rosen JB. Attenuation of kindling-induced decreases in NT-3 mRNA by thyroid hormone depletion. Epilepsy Res. 1998;29(3):211\u201320.","journal-title":"Epilepsy Res"},{"issue":"2","key":"377_CR113","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/epi.17117","volume":"63","author":"AM Rochtus","year":"2022","unstructured":"Rochtus AM, Herijgers D, Jansen K, Decallonne B. Antiseizure medications and thyroid hormone homeostasis: literature review and practical recommendations. Epilepsia. 2022;63(2):259\u201370.","journal-title":"Epilepsia"},{"issue":"1","key":"377_CR114","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/ane.13026","volume":"139","author":"MJ Einarsdottir","year":"2019","unstructured":"Einarsdottir MJ, Olafsson E, Sigurjonsdottir HA. Antiepileptic drugs are associated with central hypothyroidism. Acta Neurol Scand. 2019;139(1):64\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"377_CR115","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s13760-018-0908-x","volume":"120","author":"O G\u00fcng\u00f6r","year":"2020","unstructured":"G\u00fcng\u00f6r O, \u00d6zkaya AK, Temiz F. The effect of antiepileptic drugs on thyroid hormonal function: valproic acid and phenobarbital. Acta Neurol Belg. 2020;120(3):615\u20139.","journal-title":"Acta Neurol Belg"},{"issue":"6","key":"377_CR116","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1586\/17512433.2015.1091302","volume":"8","author":"SA Hamed","year":"2015","unstructured":"Hamed SA. The effect of antiepileptic drugs on thyroid hormonal function: causes and implications. Expert Rev Clin Pharmacol. 2015;8(6):741\u201350.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"43","key":"377_CR117","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012938","volume":"97","author":"Z Miyake","year":"2018","unstructured":"Miyake Z, Ishii K, Tamaoka A. Hypothyroidism induced by phenytoin and gabapentin. Medicine (Baltimore). 2018;97(43): e12938.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"377_CR118","first-page":"31","volume":"14","author":"HH Elshorbagy","year":"2020","unstructured":"Elshorbagy HH, Barseem NF, Suliman HA, Talaat E, Alshokary AH, Abdelghani WE, et al. the impact of antiepileptic drugs on thyroid function in children with epilepsy: new versus old. Iran J Child Neurol. 2020;14(1):31\u201341.","journal-title":"Iran J Child Neurol"},{"key":"377_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105542","volume":"167","author":"H-Q Wang","year":"2021","unstructured":"Wang H-Q, Wang Z-Z, Chen N-H. The receptor hypothesis and the pathogenesis of depression: Genetic bases and biological correlates. Pharmacol Res. 2021;167: 105542.","journal-title":"Pharmacol Res"},{"issue":"Suppl 1","key":"377_CR120","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1186\/1472-6874-4-S1-S19","volume":"4","author":"DE Stewart","year":"2004","unstructured":"Stewart DE, Gucciardi E, Grace SL. Depression. BMC Womens Health. 2004;4(Suppl 1):S19.","journal-title":"BMC Womens Health"},{"issue":"10161","key":"377_CR121","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299\u2013312.","journal-title":"Lancet"},{"issue":"4","key":"377_CR122","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/mp.2016.120","volume":"22","author":"J Keller","year":"2017","unstructured":"Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GM, et al. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry. 2017;22(4):527\u201336.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"377_CR123","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biopsych.2020.01.014","volume":"88","author":"Y Milaneschi","year":"2020","unstructured":"Milaneschi Y, Lamers F, Berk M, Penninx BWJH. Depression heterogeneity and its biological underpinnings: toward immunometabolic depression. Biol Psychiatry. 2020;88(5):369\u201380.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"377_CR124","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.4103\/jfmpc.jfmpc_456_19","volume":"8","author":"MYH Mohammad","year":"2019","unstructured":"Mohammad MYH, Bushulaybi NA, AlHumam AS, AlGhamdi AY, Aldakhil HA, Alumair NA, et al. Prevalence of depression among hypothyroid patients attending the primary healthcare and endocrine clinics of King Fahad Hospital of the University (KFHU). J Family Med Prim Care. 2019;8(8):2708\u201313.","journal-title":"J Family Med Prim Care"},{"key":"377_CR125","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jad.2021.11.055","volume":"299","author":"D Qiao","year":"2022","unstructured":"Qiao D, Liu H, Zhang X, Lei L, Sun N, Yang C, et al. Exploring the potential of thyroid hormones to predict clinical improvements in depressive patients: a machine learning analysis of the real-world based study. J Affect Disord. 2022;299:159\u201365.","journal-title":"J Affect Disord"},{"issue":"4","key":"377_CR126","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s42000-021-00312-3","volume":"20","author":"GN Karakatsoulis","year":"2021","unstructured":"Karakatsoulis GN, Tsapakis E-M, Mitkani C, Fountoulakis KN. Subclinical thyroid dysfunction and major depressive disorder. Hormones (Athens). 2021;20(4):613\u201321.","journal-title":"Hormones (Athens)"},{"key":"377_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2021.152253","volume":"109","author":"J Airaksinen","year":"2021","unstructured":"Airaksinen J, Komulainen K, Garc\u00eda-Vel\u00e1zquez R, M\u00e4\u00e4tt\u00e4nen I, Gluschkoff K, Savelieva K, et al. Subclinical hypothyroidism and symptoms of depression: evidence from the National Health and Nutrition Examination Surveys (NHANES). Compr Psychiatry. 2021;109: 152253.","journal-title":"Compr Psychiatry"},{"key":"377_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.586939","volume":"14","author":"K G\u0142ombik","year":"2020","unstructured":"G\u0142ombik K, Detka J, Kurek A, Budziszewska B. Impaired brain energy metabolism: involvement in depression and hypothyroidism. Front Neurosci. 2020;14: 586939.","journal-title":"Front Neurosci"},{"issue":"4","key":"377_CR129","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/ijms22041599","volume":"22","author":"K G\u0142ombik","year":"2021","unstructured":"G\u0142ombik K, Detka J, Bobula B, B\u0105k J, Kusek M, Tokarski K, et al. Contribution of hypothyroidism to cognitive impairment and hippocampal synaptic plasticity regulation in an animal model of depression. Int J Mol Sci. 2021;22(4):1599.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"377_CR130","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1007\/s40618-021-01600-w","volume":"44","author":"M Bauer","year":"2021","unstructured":"Bauer M, Whybrow PC. Role of thyroid hormone therapy in depressive disorders. J Endocrinol Invest. 2021;44(11):2341\u20137.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"377_CR131","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/acps.13154","volume":"141","author":"R Lorentzen","year":"2020","unstructured":"Lorentzen R, Kj\u00e6r JN, \u00d8stergaard SD, Madsen MM. Thyroid hormone treatment in the management of treatment-resistant unipolar depression: a systematic review and meta-analysis. Acta Psychiatr Scand. 2020;141(4):316\u201326.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"377_CR132","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/ijms18030551","volume":"18","author":"R Cacabelos","year":"2017","unstructured":"Cacabelos R. Parkinson\u2019s disease: from pathogenesis to pharmacogenomics. Int J Mol Sci. 2017;18(3):551.","journal-title":"Int J Mol Sci"},{"issue":"10291","key":"377_CR133","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"8","key":"377_CR134","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK. Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2020;91(8):795\u2013808.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"377_CR135","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/00207454.2020.1744595","volume":"131","author":"Y Tan","year":"2021","unstructured":"Tan Y, Gao L, Yin Q, Sun Z, Man X, Du Y, et al. Thyroid hormone levels and structural parameters of thyroid homeostasis are correlated with motor subtype and disease severity in euthyroid patients with Parkinson\u2019s disease. Int J Neurosci. 2021;131(4):346\u201356.","journal-title":"Int J Neurosci"},{"issue":"7","key":"377_CR136","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00415-015-7780-x","volume":"262","author":"T Umehara","year":"2015","unstructured":"Umehara T, Matsuno H, Toyoda C, Oka H. Thyroid hormone level is associated with motor symptoms in de novo Parkinson\u2019s disease. J Neurol. 2015;262(7):1762\u20138.","journal-title":"J Neurol"},{"issue":"1","key":"377_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-020-01314-5","volume":"44","author":"S Mohammadi","year":"2021","unstructured":"Mohammadi S, Dolatshahi M, Rahmani F. Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors. J Endocrinol Invest. 2021;44(1):1\u201313.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"377_CR138","first-page":"292","volume":"71","author":"J-X Zhang","year":"2020","unstructured":"Zhang J-X, Li X. Changes in serum thyroid hormone levels in psychiatric patients treated with second-generation antipsychotics. Endokrynol Pol. 2020;71(4):292\u20138.","journal-title":"Endokrynol Pol"},{"issue":"12","key":"377_CR139","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3390\/ph14121330","volume":"14","author":"M Runfola","year":"2021","unstructured":"Runfola M, Perni M, Yang X, Marchese M, Bacci A, Mero S, et al. Identification of a thyroid hormone derivative as a pleiotropic agent for the treatment of Alzheimer\u2019s disease. Pharmaceuticals (Basel). 2021;14(12):1330.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"377_CR140","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1007\/s12035-015-9375-z","volume":"53","author":"M Zhang","year":"2016","unstructured":"Zhang M, Ma Z, Qin H, Yao Z. Thyroid hormone potentially benefits multiple sclerosis via facilitating remyelination. Mol Neurobiol. 2016;53(7):4406\u201316.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"377_CR141","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","volume":"268","author":"N Cunniffe","year":"2021","unstructured":"Cunniffe N, Coles A. Promoting remyelination in multiple sclerosis. J Neurol. 2021;268(1):30\u201344.","journal-title":"J Neurol"},{"key":"377_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2021.100901","volume":"61","author":"M Pagnin","year":"2021","unstructured":"Pagnin M, Kondos-Devcic D, Chincarini G, Cumberland A, Richardson SJ, Tolcos M. Role of thyroid hormones in normal and abnormal central nervous system myelination in humans and rodents. Front Neuroendocrinol. 2021;61: 100901.","journal-title":"Front Neuroendocrinol"},{"key":"377_CR143","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ebiom.2017.10.016","volume":"25","author":"JY Lee","year":"2017","unstructured":"Lee JY, Kim MJ, Deliyanti D, Azari MF, Rossello F, Costin A, et al. Overcoming monocarboxylate transporter 8 (MCT8)-deficiency to promote human oligodendrocyte differentiation and myelination. EBioMedicine. 2017;25:122\u201335.","journal-title":"EBioMedicine"},{"key":"377_CR144","doi-asserted-by":"publisher","first-page":"5496891","DOI":"10.1155\/2019\/5496891","volume":"2019","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Petratos S. Oligodendroglial lineage cells in thyroid hormone-deprived conditions. Stem Cells Int. 2019;2019:5496891.","journal-title":"Stem Cells Int"},{"issue":"8","key":"377_CR145","doi-asserted-by":"publisher","first-page":"e126329","DOI":"10.1172\/jci.insight.126329","volume":"4","author":"MD Hartley","year":"2019","unstructured":"Hartley MD, Banerji T, Tagge IJ, Kirkemo LL, Chaudhary P, Calkins E, et al. Myelin repair stimulated by CNS-selective thyroid hormone action. JCI Insight. 2019;4(8):e126329.","journal-title":"JCI Insight"},{"issue":"352","key":"377_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577468","volume":"15","author":"P Chaudhary","year":"2021","unstructured":"Chaudhary P, Marracci G, Calkins E, Pocius E, Bensen A, Scanlan T, et al. Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE. J Neuroimmunol. 2021;15(352): 577468.","journal-title":"J Neuroimmunol"},{"key":"377_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102015","volume":"41","author":"L Wooliscroft","year":"2020","unstructured":"Wooliscroft L, Altowaijri G, Hildebrand A, Samuels M, Oken B, Bourdette D, et al. Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: a dose-ranging study with assessment of reliability of visual outcomes. Mult Scler Relat Disord. 2020;41: 102015.","journal-title":"Mult Scler Relat Disord"},{"key":"377_CR148","doi-asserted-by":"publisher","first-page":"13659","DOI":"10.1038\/s41598-019-49876-6","volume":"9","author":"E-H Lee","year":"2019","unstructured":"Lee E-H, Kim S-M, Kim C-H, Pagire SH, Pagire HS, Chung HY, et al. Dopamine neuron induction and the neuroprotective effects of thyroid hormone derivatives. Sci Rep. 2019;9:13659.","journal-title":"Sci Rep"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-022-00377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-022-00377-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-022-00377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T19:03:07Z","timestamp":1666378987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-022-00377-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":148,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["377"],"URL":"https:\/\/doi.org\/10.1007\/s43440-022-00377-w","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}